Themis Medicare announces Q2 results: Profit Rises by 26.24% YoY

The comprehensive analytics outlining the performance and outlook of Themis Medicare Ltd.‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Themis Medicare Ltd.’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 11.67 %. However, it did see a marginal slip of -4.87 % from the previous quarter. Expenses ticked up slightly by 6.46 % quarter-on-quarter, aligning with the annual rise of 8.13 %. Operating profit, while up 38.03 % compared to last year, faced a quarter-on-quarter dip of -41.28 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.8 %, but a shrinkage of -9.08 % sequentially. Other income rose by 18.56 % compared to the last quarter, despite an annual decline of -53.36 %. Interest expenses surged remarkably by 3.39 % from the previous quarter, yet the year-over-year increase remains at a moderate 19.61 %. Depreciation costs climbed by 1.66 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -20.2 %. Profit before tax grew annually by 37.37 % but saw a reduction from the preceding quarter by -47.24 %.
Tax expenses as a percentage of profits decreased slightly by -0.92 % compared to last year, with a more notable quarter-on-quarter decrease of -0.07 %. Net profit rose by 26.24 % year-on-year but witnessed a -42.12 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -87.38 % but a quarterly fall of -42.16 %. In summary, Themis Medicare Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Themis Medicare Ltd.’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 11.67 % year-on-year growth, although there was a slight dip of -4.87 % from the previous quarter. Expenses rose by 8.13 % compared to the previous year, with a 6.46 % increase quarter-on-quarter. Operating Profit surged by 38.03 % annually, and saw a -41.28 % decrease from the last quarter.
Net Profit showed yearly increase of 26.24 %, and experienced a -42.12 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -87.38 % annually, however dipped by -42.16 % compared to the last quarter. In essence, while Themis Medicare Ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.